Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015
The 2013-2016 outbreak of Ebola virus disease (EVD) in West Africa infected >28,000 people, including >11,000 who died, and disrupted social life in the region. We retrospectively studied clinical signs and symptoms and risk factors for fatal outcome among 31 Ebola virus-positive patients admitted to the Ebola Treatment Center in Moyamba District, Sierra Leone. We found a higher rate of bleeding manifestations than reported elsewhere during the outbreak. Significant predictors for death were shorter time from symptom onset to admission, male sex, high viral load on initial laboratory testing, severe pain, diarrhea, bloody feces, and development of other bleeding manifestations during hospitalization. These risk factors for death could be used to identify patients in need of more intensive medical support. The lack of fever in as many as one third of EVD cases may have implications for temperature-screening practices and case definitions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Emerging infectious diseases - 22(2016), 9 vom: 07. Sept., Seite 1537-44 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haaskjold, Yngvar Lunde [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical features |
|---|
| Anmerkungen: |
Date Completed 01.02.2018 Date Revised 30.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3201/eid2209.151621 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM261115081 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM261115081 | ||
| 003 | DE-627 | ||
| 005 | 20231224194847.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3201/eid2209.151621 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0870.xml |
| 035 | |a (DE-627)NLM261115081 | ||
| 035 | |a (NLM)27268303 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haaskjold, Yngvar Lunde |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015 |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.02.2018 | ||
| 500 | |a Date Revised 30.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The 2013-2016 outbreak of Ebola virus disease (EVD) in West Africa infected >28,000 people, including >11,000 who died, and disrupted social life in the region. We retrospectively studied clinical signs and symptoms and risk factors for fatal outcome among 31 Ebola virus-positive patients admitted to the Ebola Treatment Center in Moyamba District, Sierra Leone. We found a higher rate of bleeding manifestations than reported elsewhere during the outbreak. Significant predictors for death were shorter time from symptom onset to admission, male sex, high viral load on initial laboratory testing, severe pain, diarrhea, bloody feces, and development of other bleeding manifestations during hospitalization. These risk factors for death could be used to identify patients in need of more intensive medical support. The lack of fever in as many as one third of EVD cases may have implications for temperature-screening practices and case definitions | ||
| 650 | 4 | |a Historical Article | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Ebola hemorrhagic fever | |
| 650 | 4 | |a Ebola virus disease | |
| 650 | 4 | |a Sierra Leone | |
| 650 | 4 | |a clinical features | |
| 650 | 4 | |a fatal disease | |
| 650 | 4 | |a neglected diseases | |
| 650 | 4 | |a risk factors | |
| 650 | 4 | |a viruses | |
| 700 | 1 | |a Bolkan, Håkon Angell |e verfasserin |4 aut | |
| 700 | 1 | |a Krogh, Kurt Østhuus |e verfasserin |4 aut | |
| 700 | 1 | |a Jongopi, James |e verfasserin |4 aut | |
| 700 | 1 | |a Lundeby, Karen Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Mellesmo, Sindre |e verfasserin |4 aut | |
| 700 | 1 | |a Garcés, Pedro San José |e verfasserin |4 aut | |
| 700 | 1 | |a Jøsendal, Ola |e verfasserin |4 aut | |
| 700 | 1 | |a Øpstad, Åsmund |e verfasserin |4 aut | |
| 700 | 1 | |a Svensen, Erling |e verfasserin |4 aut | |
| 700 | 1 | |a Fuentes, Luis Matias Zabala |e verfasserin |4 aut | |
| 700 | 1 | |a Kamara, Alfred Sandy |e verfasserin |4 aut | |
| 700 | 1 | |a Riera, Melchor |e verfasserin |4 aut | |
| 700 | 1 | |a Arranz, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, David P |e verfasserin |4 aut | |
| 700 | 1 | |a Stamper, Paul D |e verfasserin |4 aut | |
| 700 | 1 | |a Austin, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Moosa, Alfredo J |e verfasserin |4 aut | |
| 700 | 1 | |a Marke, Dennis |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Shoaib |e verfasserin |4 aut | |
| 700 | 1 | |a Eide, Geir Egil |e verfasserin |4 aut | |
| 700 | 1 | |a Berg, Åse |e verfasserin |4 aut | |
| 700 | 1 | |a Blomberg, Bjørn |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emerging infectious diseases |d 1995 |g 22(2016), 9 vom: 07. Sept., Seite 1537-44 |w (DE-627)NLM088704254 |x 1080-6059 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2016 |g number:9 |g day:07 |g month:09 |g pages:1537-44 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3201/eid2209.151621 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2016 |e 9 |b 07 |c 09 |h 1537-44 | ||